ArticleFrontiers in oncology2019

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.

Giselle V Ripoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.